|
|
Volumn 45, Issue 1, 2006, Pages 112-
|
|
The impact of anti-TNF-α therapy on the nature of service provision [1]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AUROTHIOMALATE;
AZATHIOPRINE;
CYCLOPHOSPHAMIDE;
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
ETANERCEPT;
HYDROXYCHLOROQUINE;
INFLIXIMAB;
LEFLUNOMIDE;
METHOTREXATE;
PENICILLAMINE;
PREDNISOLONE;
SALAZOSULFAPYRIDINE;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ADULT;
BIOLOGICAL THERAPY;
CLINICAL ARTICLE;
COST UTILITY ANALYSIS;
DRUG COST;
DRUG DOSE REDUCTION;
ECONOMIC EVALUATION;
HOSPITAL BED UTILIZATION;
HUMAN;
LETTER;
OUTPATIENT CARE;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
AMBULATORY CARE;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
COHORT STUDIES;
DELIVERY OF HEALTH CARE;
HOSPITALIZATION;
HUMANS;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 29844446133
PISSN: 14620324
EISSN: 14620332
Source Type: Journal
DOI: 10.1093/rheumatology/kei127 Document Type: Letter |
|
Times cited : (10)
|
|
References (2)
|
